Argitalpenak (82) María Pilar Civeira Murillo argitalpenak

2014

  1. Characterization of the CD40L/Oncostatin M/Oncostatin M receptor axis as an antiviral and immunostimulatory system disrupted in chronic HCV infection

    Journal of Hepatology, Vol. 60, Núm. 3, pp. 482-489

  2. Dysregulation of interferon regulatory factors impairs the expression of immunostimulatory molecules in hepatitis C virus genotype 1-infected hepatocytes

    Gut, Vol. 63, Núm. 4, pp. 665-673

2012

  1. Aprendizaje de la historia clínica con pacientes simulados en el grado de Medicina

    FEM. Revista de la Fundación Educación Médica, Vol. 15, Núm. 1, pp. 47-52

  2. Learning to take medical histories through patients simulation in undergraduate Medical School students

    Educacion Medica, Vol. 15, Núm. 1, pp. 47-52

2009

  1. El tratado de Bolonia:: implicaciones en la enseñanza de medicina

    FEM. Revista de la Fundación Educación Médica, Vol. 12, Núm. 3, pp. 1-5

2008

  1. Implication of human N-α-acetyltransferase 5 in cellular proliferation and carcinogenesis

    Oncogene, Vol. 27, Núm. 58, pp. 7296-7306

  2. Monocyte-derived dendritic cells from HCV-infected patients transduced with an adenovirus expressing NS3 are functional when stimulated with the TLR3 ligand poly(I:C)

    Journal of Viral Hepatitis, Vol. 15, Núm. 11, pp. 782-789

2007

  1. HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway

    Antiviral Research, Vol. 76, Núm. 2, pp. 194-197

  2. Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection

    Journal of Virology, Vol. 81, Núm. 7, pp. 3662-3666

2006

  1. Altered expression and activation of signal transducers and activators of transcription (STATs) in hepatitis C virus infection: In vivo and in vitro studies

    Gut, Vol. 55, Núm. 8, pp. 1188-1196

  2. Characterization of T-cell responses against immunodominant epitopes from hepatitis C virus E2 and NS4a proteins

    Journal of Viral Hepatitis, Vol. 13, Núm. 1, pp. 47-55

  3. Recombinant Adenoviral Vectors Turn on the Type I Interferon System without Inhibition of Transgene Expression and Viral Replication

    Molecular Therapy, Vol. 14, Núm. 1, pp. 129-138

2005

  1. Hepatitis C virus infection of primary tupaia hepatocytes leads to selection of quasispecies variants, induction of interferon-stimulated genes and NF-κB nuclear translocation

    Journal of General Virology, Vol. 86, Núm. 11, pp. 3065-3074

2004

  1. Enfermedades hepáticas de patogenia inmunológica

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 9, pp. 552-560

  2. IFN-α5 mediates stronger Tyk2-stat-dependent activation and higher expression of 2′,5′-oligoadenylate synthetase than IFN-α2 in liver cells

    Journal of Interferon and Cytokine Research, Vol. 24, Núm. 8, pp. 497-503

  3. Protocolo diagnóstico de la hepatopatía con sospecha patogénica autoinmune

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 9, Núm. 9, pp. 582-584

2002

  1. Genotype mixtures of hepatitis B virus in patients treated with interferon

    Journal of Infectious Diseases, Vol. 186, Núm. 6, pp. 752-759

2001

  1. Dendritic cells infected with recombinant defective adenoviruses undergo NF-kB activation and partial maturation

    INMUNOLOGÍA, Vol. 20, Núm. 3, pp. 130-142

  2. Expression of interferon-α subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: A role for interferon-α5

    Journal of Viral Hepatitis, Vol. 8, Núm. 2, pp. 103-110

  3. Nuclear factor-kB in the liver of patients with chronic hepatitis C: Decreased RelA expression is associated with enhanced fibrosis progression

    Hepatology, Vol. 34, Núm. 5, pp. 1041-1048